Items where Author is "Rodgers, S"
Up a level |
PALMER, K., MOORE, J., EVERARD, M., HARRIS, J.D., RODGERS, S., REES, R.C., MURRAY, A.K., MASCARI, R., KIRKWOOD, J., RICHES, P.G., FISHER, C., THOMAS, J.M., HARRIES, M., JOHNSTON, S.R.D., COLLINS, M.K.L. and GORE, M.E., 1999. Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma. Human Gene Therapy, 10 (8), pp. 1261-1268. ISSN 1043-0342
GILLESPIE, A.M., RODGERS, S., WILSON, A.P., TIDY, J., REES, R.C., COLEMAN, R.E. and MURRAY, A.K., 1998. MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue. British Journal of Cancer, 78 (6), pp. 816-821. ISSN 0007-0920
VORA, A.R., RODGERS, S., PARKER, A.J., START, R., REES, R.C. and MURRAY, A.K., 1997. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. British Journal of Cancer, 76 (7), pp. 836-844. ISSN 0007-0920
MULCAHY, K.A., RIMOLDI, D., BRASSEUR, F., RODGERS, S., LIENARD, D., MARCHAND, M., RENNIE, I.G., MURRAY, A.K., MCINTYRE, C.A., PLATTS, K.E., LEYVRAZ, S., BOON, T. and REES, R.C., 1996. Infrequent expression of the MAGE gene family in uveal melanomas. International Journal of Cancer, 66 (6), pp. 738-742. ISSN 0020-7136
RODGERS, S., REES, R.C. and HANCOCK, B.W., 1994. Changes in the Phenotypic Characteristics of Eosinophils from Patients Receiving Recombinant Human Interleukin-2 (Rhil-2) Therapy. British Journal of Haematology, 86 (4), pp. 746-753. ISSN 0007-1048
MCINTYRE, C.A., CHAPMAN, K., REEDER, S., DORREEN, M.S., BRUCE, L., RODGERS, S., HAYAT, K., SCHREENIVASAN, T., SHERIDAN, E., HANCOCK, B.W. and REES, R.C., 1992. Treatment of Malignant-Melanoma and Renal-Cell Carcinoma with Recombinant Human Interleukin-2 - Analysis of Cytokine Levels in Sera and Culture Supernatants. European Journal of Cancer, 28 (1), pp. 58-63. ISSN 0959-8049